

Fundamental dimension Equity attribute | GESILeader $0.00020.00% Cap $68.79KP/E -0.0x QuantScore34/100 | AVCVFPeer $0.04140.00% Cap $177.8KP/E -7.9x QuantScore19/100 | AVRTFPeer $0.00260.00% Cap $237.7KP/E -0.7x QuantScore28/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
75/100 |
51/100 |
60/100 |
Valuation Multiples, PEG & DCF upside | 25/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 38/100 | 20/100 | 20/100 |
Growth Revenue / earnings growth & margins | 0/100 | 6/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -7.9x | -0.7x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 432.7x | -17.8x | -11.3x |
Price / Sales | — | — | — |
Price / Free Cash Flow | -0.9x | -8.9x | -18.6x |
PEG ratio | 0.00 | -0.18 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 1 / 9 | 1 / 9 |
Altman Z-Score | -5.87 (Distress) | -5412.82 (Distress) | -7892.55 (Distress) |
Total debt / equity | 0.09 | -0.40 | -0.70 |
Quick ratio | 0.1x | 0.0x | 0.0x |
Interest coverage | — | -9.2x | -2.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | -10677.9% | -2.6% | -187.6% |
Gross margin (TTM) | 0.0% | 0.0% | 0.0% |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | 0.0% |
3M return | +0.0% | +206900.0% | -49.0% |
6M return | -33.3% | -54.0% | -93.5% |
Year to date | -80.0% | -54.0% | -93.5% |
1Y return | -80.0% | -58.6% | -21.2% |
3Y return | -99.7% | -44.9% | -69.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.014 -7092.9% premium | $-0.071 -271.6% premium | $-0.0099 -479.9% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |